Neuland Laboratories Limited
Neuland Laboratories released the transcript for its Q4 & FY26 earnings call held on May 12, 2026. The company reported a significant increase in Q4 revenue and net profit, with full year revenue growing 37.1%.
May 16 2026 16:12:57
Neuland Laboratories shares rally 7% as profit jumps seven-fold and revenue doubles in Q4
Neuland Laboratories reported a significant increase in its Q4 financial performance, with profit jumping seven-fold and revenue doubling. This strong quarterly update led to a 7% rally in the company's shares.
May 13 2026 10:36:41
Neuland Laboratories Ltd - 524558 - Announcement under Regulation 30 (LODR)-Press Release / Media Release (Revised)
Neuland Labs reported strong FY26 performance with total income reaching Rs.2,053.1 crore. Q4 total income rose 134.9% YoY to Rs.788.7 crore, and net profit surged 666.3% YoY to Rs.212.5 crore.
May 12 2026 19:16:04
Neuland Laboratories Ltd - 524558 - The Record Date For The Purpose Of Determining The Shareholder Eligible To Receive The Final Dividend For The Financial Year Ended March 31, 2026, Has Been Fixed As July 24, 2026
Neuland Laboratories set July 24, 2026, as the Record Date. This is for identifying shareholders entitled to a final dividend of ₹34 per equity share for FY 2025-26.
May 12 2026 17:50:46
Neuland Laboratories Ltd - 524558 - Disclosure Under Regulation 30 Of SEBI Listing Regulations
Neuland Laboratories approved a significant capacity expansion of 120.5 KL at its Unit 1 facility. This Rs.143.4 crore investment, funded by internal accruals and borrowings, is aimed at meeting the growing demand from customers and will be completed within 12-18 months.
May 12 2026 17:29:37
Neuland Laboratories Ltd - 524558 - Announcement under Regulation 30 (LODR)-Press Release / Media Release (Revised)
Neuland Laboratories announced strong Q4 FY26 results, with total income rising 134.9% YoY to Rs.788.7 crore and profit after tax increasing 666.3% to Rs.212.5 crore. The full year FY26 total income reached Rs.2,053.1 crore.
May 12 2026 17:15:01
Neuland Laboratories Ltd - 524558 - Corporate Action-Board approves Dividend
Neuland Laboratories declared a final dividend of ₹34 per equity share for FY2025-26. The record date for eligibility is July 24, 2026, with payment to shareholders expected after August 9, 2026.
May 12 2026 17:08:39
Neuland Labs Q4 Result: Profit surges 7x to ₹213 crore as export orders drive strong quarter
Neuland Laboratories reported a significant financial downturn for Q4 FY26, with profit after tax plummeting by 72.63% to ₹27.81 crore and total income decreasing by 17.50% to ₹328.36 crore. The company's operating profit also fell 51.38% to ₹34.18 crore.
May 12 2026 16:55:52
Neuland Laboratories Ltd - 524558 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Neuland Laboratories reported exceptionally strong Q4 FY26 financial results. Total income increased by 134.9% YoY to Rs.788.7 crore, while net profit (PAT) saw a substantial 666.3% rise to Rs.212.5 crore. EBITDA margin also expanded significantly to 40.5%.
May 12 2026 16:36:00
Read More